IJSRP, Volume 5, Issue 7, July 2015 Edition [ISSN 2250-3153]
Kailash Mittal, Abhishek Bahadur Singh, Nishu Bala
Introduction: Head and neck cancers constitute 5% of all cancers worldwide with an annual incidence of about 5,00,000 cases of which two-thirds are locally advanced. Radiotherapy with or without chemotherapy forms an integral part of the multimodal management. Seven to eight weeks treatment is accompanied by its acute & late reactions, of which xerostomia is one of the major complications of Radiotherapy.